Study of CnU Cap. 500 mg for Biliary Dyspepsia
Part of Digestive system clinical trials.
This trial tests a medication called CnU Cap. 500 mg to see if it helps people with biliary dyspepsia, a type of upper belly pain caused by the gallbladder or bile ducts. It may help if you have episodes of steady pain in the upper right belly that last at least 30 minutes and disrupt your daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have pain in the upper middle or upper right part of your belly that builds to a steady level, lasts 30 minutes or more, happens at different times (not every day), and is severe enough to interrupt daily activities or send you to the ER.
- This pain is not mainly related to bowel movements, and is not mainly relieved by changing position or taking acid-reducing medicine.
- An ultrasound done during screening shows no gallstones or other problems that could explain the pain.
- You are willing to stop certain medications as required before starting the trial.
- You are not pregnant, not breastfeeding, and agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if CnU capsules shrink cholesterol gallstones in people who have stones smaller than 15 millimeters. It aims to help people dissolve stones without surgery.
This study tests whether a medicine called 4-MUST can safely reduce pain and digestive symptoms caused by chronic gallbladder problems. You'll take tablets for several weeks while researchers track how well the medicine works and any side effects.
This trial tests an investigational tablet for people with long-term gallbladder inflammation (chronic cholecystitis) or bile duct movement problems (biliary dyskinesia). It aims to see if the tablet reduces stomach pain and other digestive symptoms.
This trial tests whether ursodeoxycholic acid (a bile medicine) can help prevent complications from gallstone-related acute pancreatitis from coming back after you leave the hospital. It may help reduce repeat problems linked to gallstones, especially after an initial pancreatitis episode.
This phase 3 trial tests duloxetine for preventing pancreatitis after ERCP in adults with normal baseline amylase/lipase and without certain comorbidities.
This trial compares a new ultrasound-guided way to drain the gallbladder using an endoscope versus non-endoscopic treatments. It’s for adults with acute gallbladder inflammation (from stones) who cannot have surgery, aiming to reduce complications and improve recovery.
Hear when a new Biliary Dyspepsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.